Showing results (361-370 of 527) with videos related to
Sort By:
Pageof 53
Journal of Crohn'S & Colitis|April 5, 2018
Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort StudyLevente Parragi, N Fournier, Jonas Zeitz, et al.Cellular and Molecular Gastroenterology and Hepatology|March 2, 2017
Anti-inflammatory Function of High-Density Lipoproteins via Autophagy of IκB KinaseRagam Gerster, Jyrki J Eloranta, Martin Hausmann, et al.Inflammatory Bowel Diseases|July 16, 2008
Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's diseaseFrauke Bataille, Christian Rohrmeier, Richard Bates, et al.Journal of Crohn'S & Colitis|August 31, 2018
Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease CourseThomas Greuter, Alberto Piller, Nicolas Fournier, et al.Digestive Diseases and Sciences|August 8, 2024
Odynophagia and Retrosternal Pain Are Common in Eosinophilic Esophagitis and Associated with an Increased Overall Symptom SeverityJeanine Karpf, Ekaterina Safroneeva, Jean-Benoit Rossel, et al.Medicine|June 1, 2017
Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort studySolvey Schüle, Jean-Benoît Rossel, Diana Frey, et al.Journal of Crohn'S & Colitis|June 28, 2015
High Rates of Smoking Especially in Female Crohn's Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation--Data from the Swiss IBD Cohort StudyLuc Biedermann, Nicolas Fournier, Benjamin Misselwitz, et al.Therapeutic Advances in Gastroenterology|September 6, 2021
Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: a 5-year analysisAlexander R Siebenhüner, Jean-Benoît Rossel, Philipp Schreiner, et al.Molecular Oncology|June 10, 2026
Loss of proton-sensing TDAG8 increases tumor progression in mouse models of colon cancerErmanno Malagola, Yasmine Illi, Anna Bircher, et al.Inflammatory Bowel Diseases|August 9, 2020
Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical ProgramGary R Lichtenstein, Gerhard Rogler, Matthew A Ciorba, et al.Pageof 53